ZA927522B - Vanadium compositions. - Google Patents

Vanadium compositions.

Info

Publication number
ZA927522B
ZA927522B ZA927522A ZA927522A ZA927522B ZA 927522 B ZA927522 B ZA 927522B ZA 927522 A ZA927522 A ZA 927522A ZA 927522 A ZA927522 A ZA 927522A ZA 927522 B ZA927522 B ZA 927522B
Authority
ZA
South Africa
Prior art keywords
compositions
vanadium
vanadium compositions
oxovanadium
monoprotic
Prior art date
Application number
ZA927522A
Other languages
English (en)
Inventor
John Hugh Mcneill
Hamid Reza Hoveyda
Chris Orvig
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Publication of ZA927522B publication Critical patent/ZA927522B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA927522A 1991-09-30 1992-09-30 Vanadium compositions. ZA927522B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/767,510 US5300496A (en) 1991-09-30 1991-09-30 Complexed vanadium for the treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
ZA927522B true ZA927522B (en) 1993-06-16

Family

ID=25079727

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA927522A ZA927522B (en) 1991-09-30 1992-09-30 Vanadium compositions.

Country Status (13)

Country Link
US (1) US5300496A (xx)
EP (2) EP0811380A3 (xx)
JP (1) JP3515107B2 (xx)
AT (1) ATE162716T1 (xx)
AU (1) AU2649792A (xx)
CA (1) CA2120338A1 (xx)
DE (1) DE69224293T2 (xx)
DK (1) DK0606318T3 (xx)
ES (1) ES2112329T3 (xx)
GR (1) GR3026654T3 (xx)
NZ (1) NZ244569A (xx)
WO (1) WO1993006811A2 (xx)
ZA (1) ZA927522B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527790A (en) * 1991-09-30 1996-06-18 The University Of British Columbia Bis(maltolato)oxovanadium compositions for the treatment of elevated blood sugar
US5866563A (en) * 1991-09-30 1999-02-02 The University Of British Columbia Vanadium compositions
GB9305735D0 (en) * 1993-03-19 1993-05-05 North John R Novel agent for controlling cell activity
US5871779A (en) * 1994-01-18 1999-02-16 Mount Sinai Hospital Corporation Treatment of arthropathies with vanadate compounds or analogues thereof
US5565491A (en) * 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
GB9416767D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
US5863519A (en) * 1994-08-18 1999-01-26 Nycomed Imaging As Composition and method of MRI using both a positive and a negative contrast agent
WO1996005867A2 (en) * 1994-08-18 1996-02-29 Nycomed Imaging A/S Compositions
GB9416768D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
US5547685A (en) * 1995-05-16 1996-08-20 Eli Lilly And Company Methods for inhibiting bone loss with vanadyl sulfate
US5545661A (en) * 1995-05-16 1996-08-13 Eli Lilly And Company Methods for inhibiting bone loss with bis-pyrone oxovanadium compounds
US5885980A (en) * 1996-06-25 1999-03-23 Enrique G. Gutierrez Composition and method for treating diabetes
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
US6232340B1 (en) 1997-04-24 2001-05-15 Angiotech Pharmaceuticals, Inc. Vanadium complexes and derivatives thereof and methods related thereto
EP0984971A1 (en) * 1997-04-24 2000-03-15 Angiotech Pharmaceuticals, Inc. Vanadium complexes and derivatives thereof and methods related thereto
US6245808B1 (en) * 1998-11-05 2001-06-12 Parker Hughes Institute Oxy-vanadium (IV) complexes having spermicidal activity
US6432941B1 (en) 1998-01-20 2002-08-13 Parker Hughes Institute Vanadium compounds for treating cancer
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
WO2000015211A2 (en) 1998-09-17 2000-03-23 Akesis Pharmaceuticals, Inc. Compositions of chromium or vanadium with antidiabetics for glucose metabolism disorders
US6287586B1 (en) 1998-09-18 2001-09-11 The University Of British Columbia Pharmaceutical compositions of vanadium biguanide complexes and their use
WO2000024730A1 (en) 1998-10-28 2000-05-04 The University Of British Columbia Organic vanadium(iii) complexes and their use
GB2396106B (en) * 2002-12-12 2006-11-15 Johnson & Johnson Medical Ltd Wound dressings comprising enzyme inhibitors
AU2005259231A1 (en) * 2004-07-02 2006-01-12 Genmedica Therapeutics Sl Arylalkylamine vanadium (V) salts for the treatment and/or prevention of diabetes mellitus
US20060165814A1 (en) * 2004-12-16 2006-07-27 Genmedica Therapeutics Sl Amines, combination of amines and vanadium and amine vanadium salts for the treatment or prevention of dyslipidemia
US20070066682A1 (en) * 2005-07-01 2007-03-22 Exposito Miriam R Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus
US20080070987A1 (en) * 2006-05-12 2008-03-20 Francesc Yraola Font Meta-xylylenediamine vanadate salts
AU2012226703A1 (en) 2011-03-07 2013-10-17 Cfm Pharma Holding Bv Use of vanadium compounds for maintaining normaglycemia in a mammal
WO2012131689A1 (en) 2011-03-25 2012-10-04 Chaudhuri Mihir K Insulin mimetic active comprising oxodiperoxo vanadates and a pharamaceutical composition obtained thereof
JP7349052B2 (ja) * 2019-06-24 2023-09-22 湖南方升泰医薬科技有限公司 金属錯体の新規応用
CN111035652B (zh) * 2020-01-08 2021-08-24 辽宁大学 钒酸盐酪蛋白复合物在制备降糖药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1277599C (en) * 1986-10-16 1990-12-11 Barry I. Posner Vanadium - peroxide compositions as insulin mimickers
FR2619382B1 (fr) * 1987-08-11 1990-05-04 Lazaro Rene Compose organo-mineral de vanadyle, procede d'obtention d'un tel compose, composition pharmaceutique contenant ce compose organo-mineral
JPH02292217A (ja) * 1989-05-08 1990-12-03 Otsuka Pharmaceut Co Ltd 糖尿病治療薬

Also Published As

Publication number Publication date
AU2649792A (en) 1993-05-03
CA2120338A1 (en) 1993-04-15
DE69224293D1 (de) 1998-03-05
JPH06511244A (ja) 1994-12-15
EP0606318A1 (en) 1994-07-20
GR3026654T3 (en) 1998-07-31
EP0811380A2 (en) 1997-12-10
EP0811380A3 (en) 1999-01-20
WO1993006811A2 (en) 1993-04-15
DK0606318T3 (da) 1998-09-23
US5300496A (en) 1994-04-05
ES2112329T3 (es) 1998-04-01
NZ244569A (en) 1995-04-27
JP3515107B2 (ja) 2004-04-05
EP0606318B1 (en) 1998-01-28
ATE162716T1 (de) 1998-02-15
WO1993006811A3 (en) 1993-06-24
DE69224293T2 (de) 1998-07-09

Similar Documents

Publication Publication Date Title
ZA927522B (en) Vanadium compositions.
DE69313284D1 (de) Verfahren zur deliquifizierung und zum bleichen von einem ligenocellulosischen material
AP2000001929A0 (en) Substituted indolealkanoic acids.
MY129973A (en) Sulphonylbenzyl-substituted pyridones.
IL109604A0 (en) Substituted mono- and bipyridylmethyl- pyridones, process for their preparation and pharmaceutical compositions containing them
IL92007A0 (en) Pharmaceutical compositions containing gestodene
AU1473792A (en) Treatment of periodontitis
ZA967732B (en) Pharmaceutical combination preparations containing erythropoietin and ferric complexes.
EP0344880A3 (en) Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer
HU911928D0 (en) Process for the production of chelates and its complexes containing orto ligating functional group, and the medical preparations containing thereof
EP0445743A3 (en) Complexes and chelates of azithromycin as antiulcer drugs
GEP20032914B (en) Derivatives of 1,3,4-Oxadiazolone
DK0977582T3 (da) Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater
EP0202673A3 (en) Titanocene complexes having a cytostatic activity
GB9405012D0 (en) Polymerisation catalysts
IL89654A (en) Pharmaceutical combination compositions for treating hypertension
DE3160552D1 (en) Medicine containing a biflavanone compound
Burnett et al. A bi-copper (I)/bi-copper (II) redox cycle in the co-ordination and activation of dioxygen by a bi-copper (I) complex of a macrocyclic ligand
GB1525844A (en) 2-carbamoyl-1,2,4,5-tetrahydro-3h-2-benzazepin-3-ones
EP0171984A3 (en) Combination modality cancer therapy